Synonyms: compound 64 [WO2019197546A1]
Compound class:
Synthetic organic
Comment: The chemical structure for mocaciclib was obtained from WHO proposed INN list 131 (August 2024), wherein it is described as a cyclin-dependent kinase (CDK) inhibitor and antineoplastic. This is one of the structures claimed in patent WO2019197546A1, with data indicating that it is a CDK7 inhibitor [1]. We predict mocaciclib is the INN for Qurient Therapeutics' clinical lead selective CDK7 inhibitor Q901,
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|